Literature DB >> 16211206

Simple clinical criteria to determine the prognosis of heart failure.

J Thomas Heywood1, Wafaa Elatre, Ramdas G Pai, Sharon Fabbri, Bonnie Huiskes.   

Abstract

OBJECTIVE: To determine whether easily obtained clinical parameters serve as predictors of survival in patients with congestive heart failure. Several scoring systems to predict heart failure survival have been developed; however, many of these deal principally with transplant recipients or do not account for a patient's response to therapy.
METHODS: A total of 680 patients with an ejection fraction of less than 40% were included in the analysis. Baseline assessments were performed and treatment regimens were identified; patients were then followed for up to 5 years. Univariate and multivariate Cox regression models were used to determine clinically important predictors of survival. Kaplan-Meier survival functions for patients with and without the prognostic variable were constructed and mortality was calculated at 1 year and 5 years.
RESULTS: Ejection fraction improvement at 6 months, diabetes mellitus, age, serum creatinine, and blood urea nitrogen (BUN) were significant predictors for survival in the univariate model. Ejection fraction improvement, age, and BUN were significant predictors in the multivariate model. These findings were used to construct a model for predicting patient mortality. Improved ejection fraction (>15 ejection fraction units) gave a 1-year mortality of 2% and a 5-year mortality of 11%. Mortality rates according to patient age and BUN levels were also calculated.
CONCLUSION: Ejection fraction improvement was the most important predictor for survival in patients with systolic dysfunction; monitoring ejection fraction changes through repeat echocardiograms has important prognostic value. In patients without ejection fraction improvement, age and renal function are important survival determinants.

Entities:  

Mesh:

Year:  2005        PMID: 16211206     DOI: 10.1177/107424840501000305

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol Ther        ISSN: 1074-2484            Impact factor:   2.457


  8 in total

1.  Mitogen-activated protein kinase inhibitors improve heart function and prevent fibrosis in cardiomyopathy caused by mutation in lamin A/C gene.

Authors:  Wei Wu; Antoine Muchir; Jian Shan; Gisèle Bonne; Howard J Worman
Journal:  Circulation       Date:  2010-12-20       Impact factor: 29.690

Review 2.  Can we prevent or treat renal dysfunction in chronic heart failure?

Authors:  Daniela Dobre; Patrick Rossignol; Marco Metra; Faiez Zannad
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

3.  Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide.

Authors:  Hans Wedel; John J V McMurray; Magnus Lindberg; John Wikstrand; John G F Cleland; Jan H Cornel; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Michel Komajda; Timo Kuusi; Johan Vanhaecke; Finn Waagstein
Journal:  Eur J Heart Fail       Date:  2009-01-24       Impact factor: 15.534

Review 4.  Management of the cardiorenal syndrome in heart failure.

Authors:  Jigar Patel; J Thomas Heywood
Journal:  Curr Cardiol Rep       Date:  2006-05       Impact factor: 2.931

Review 5.  Current and novel renal biomarkers in heart failure.

Authors:  Kevin Damman; Adriaan A Voors; Gerjan Navis; Dirk J van Veldhuisen; Hans L Hillege
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

6.  Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients.

Authors:  Thomas Gary; Martin Pichler; Gernot Schilcher; Franz Hafner; Gerald Hackl; Peter Rief; Philipp Eller; Marianne Brodmann
Journal:  Medicine (Baltimore)       Date:  2015-06       Impact factor: 1.889

7.  Peritoneal dialysis as therapeutic option in heart failure patients.

Authors:  Leonie Grossekettler; Bastian Schmack; Katrin Meyer; Carsten Brockmann; Reinhard Wanninger; Michael M Kreusser; Lutz Frankenstein; Lars P Kihm; Martin Zeier; Hugo A Katus; Andrew Remppis; Vedat Schwenger
Journal:  ESC Heart Fail       Date:  2019-02-27

8.  Benefits of peritoneal ultrafiltration in HFpEF and HFrEF patients.

Authors:  Leonie Grossekettler; Bastian Schmack; Carsten Brockmann; Reinhard Wanninger; Michael M Kreusser; Lutz Frankenstein; Lars P Kihm; Martin Zeier; Hugo A Katus; Vedat Schwenger; Andrew Remppis
Journal:  BMC Nephrol       Date:  2020-05-14       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.